Inhibitor development in previously untreated patients with hemophilia A: a prospective long-term follow-up comparing plasma-derived and recombinant products.
暂无分享,去创建一个
J. Oldenburg | T. Klingebiel | C. E. Ettingshausen | W. Kreuz | S. Ehrenforth | I. M. Saguer | A. Zyschka | C. Ettingshausen